Nordic Capital acquires Equashield for for USD 300 million
Categories: Corporate and M&A
Finland’s Nordic Capital private equity firm has invested USD 300 million in Israeli medical device company Equashield Medical for a 25% stake, at a company valuation of USD 1.3 billion.
Nordic Capital will support the acceleration of Equashield’s growth ambitions and the achievement of its strategic objective of global leadership in compounding technologies.
Latham & Watkins LLP represents Nordic Capital in the transaction.